WallStSmart

Dollar General Corporation (DG)vsZevia Pbc (ZVIA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Dollar General Corporation generates 25339% more annual revenue ($43.08B vs $169.33M). DG leads profitability with a 3.6% profit margin vs -4.1%. DG earns a higher WallStSmart Score of 59/100 (C).

DG

Buy

59

out of 100

Grade: C

Growth: 4.7Profit: 6.0Value: 6.0Quality: 5.5
Piotroski: 5/9Altman Z: 2.08

ZVIA

Hold

38

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 6.0Quality: 6.5
Piotroski: 4/9Altman Z: 0.40
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DGUndervalued (+13.5%)

Margin of Safety

+13.5%

Fair Value

$170.04

Current Price

$103.70

$66.34 discount

UndervaluedFair: $170.04Overvalued
ZVIAUndervalued (+27.4%)

Margin of Safety

+27.4%

Fair Value

$2.26

Current Price

$1.41

$0.85 discount

UndervaluedFair: $2.26Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DG2 strengths · Avg: 8.0/10
P/E RatioValuation
16.2x8/10

Attractively priced relative to earnings

Price/BookValuation
2.6x8/10

Reasonable price relative to book value

ZVIA3 strengths · Avg: 8.7/10
Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Price/BookValuation
1.9x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
21.2%8/10

Revenue surging 21.2% year-over-year

Areas to Watch

DG4 concerns · Avg: 3.5/10
PEG RatioValuation
1.654/10

Expensive relative to growth rate

Revenue GrowthGrowth
3.4%4/10

3.4% revenue growth

Profit MarginProfitability
3.6%3/10

3.6% margin — thin

Debt/EquityHealth
1.793/10

Elevated debt levels

ZVIA4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$106.23M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-20.0%2/10

ROE of -20.0% — below average capital efficiency

Altman Z-ScoreHealth
0.402/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : DG

The strongest argument for DG centers on P/E Ratio, Price/Book.

Bull Case : ZVIA

The strongest argument for ZVIA centers on Debt/Equity, Price/Book, Revenue Growth. Revenue growth of 21.2% demonstrates continued momentum.

Bear Case : DG

The primary concerns for DG are PEG Ratio, Revenue Growth, Profit Margin. Debt-to-equity of 1.79 is elevated, increasing financial risk. Thin 3.6% margins leave little buffer for downturns.

Bear Case : ZVIA

The primary concerns for ZVIA are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

DG profiles as a value stock while ZVIA is a growth play — different risk/reward profiles.

ZVIA carries more volatility with a beta of 1.01 — expect wider price swings.

ZVIA is growing revenue faster at 21.2% — sustainability is the question.

DG generates stronger free cash flow (365M), providing more financial flexibility.

Bottom Line

DG scores higher overall (59/100 vs 38/100). ZVIA offers better value entry with a 27.4% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Dollar General Corporation

CONSUMER DEFENSIVE · DISCOUNT STORES · USA

Dollar General Corporation is an American chain of variety stores headquartered in Goodlettsville, Tennessee.

Visit Website →

Zevia Pbc

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Zevia PBC is an innovative beverage company focused on providing zero-calorie, naturally sweetened drinks that align with the rising consumer trend towards healthier lifestyles and environmental sustainability. The company's diverse portfolio includes sodas, energy drinks, and sparkling waters, all sweetened exclusively with stevia and free from artificial ingredients. With a strong distribution network and a brand ethos centered on health and social responsibility, Zevia is well-positioned for significant growth in the competitive beverage sector, making it an attractive prospect for institutional investors looking to capitalize on the clean-label market trend.

Want to dig deeper into these stocks?